Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.177 (
BIS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The main goal of this study was to prepare molecularly imprinted polymers (MIPs) with
glucose
recognition sites and to evaluate their
glucose
-binding properties for potential applications in
glucose
sensing and self-regulating insulin delivery devices. To mimic
glucose
-binding sites of natural proteins, monomers possessing functional groups similar to amino acids were used. Vinyl acetic acid (VAA), acrylamide (AAm), 4-pentenoic acid (PA), and allyl benzene (AB) were copolymerized with a cross-linking agent (N,N'-methylenebisacrylamide,
BIS
) in the presence of
glucose
as a template. The binding affinity of
glucose
to MIPs was examined by using an equilibrium dialysis technique. The dissociation constants of the MIPs were determined by Scatchard analysis. MIPs showed
glucose
-binding affinity, while polymers synthesized in the absence of
glucose
template did not show a
glucose
-binding property. MIPs composed of VAA, AAm, PA, and AB at optimized mole ratios of monomers and cross-linker showed the highest
glucose
-binding affinity, KD = 1.66 mM, which is comparable to that of a well-known
glucose
binding protein, concanavalin A (KD = 1.84 mM). The affinity between monomer and
glucose
was in the order VAA > AAm > AB > PA.
...
PMID:Glucose binding to molecularly imprinted polymers. 1218 49
Two experiments were conducted to evaluate the effect of different levels of sugars (
glucose
, lactose and raffinose) and the effect of those sugars (C(3) to C(6)) or their correspondent sugar alcohols on the dialysis of bovine semen. First, the effect of isosmotic solutions of
glucose
, lactose or raffinose at five different levels (0, 25, 50, 75, 95% V/V) on sperm motility of semen dialyzed prior to freezing were studied. These levels were used in extenders and dialysates, and the final volume was complemented with Piperazine-N-N-
BIS
(2-ethane sulfonic acid (PIPES) titrated to pH 7.0 with TRIS (hydroxymethyl) amino-methane (TRIS) to form PIPEST or a 1:1 (V/V) combination between PIPEST and sodium citrate solutions. In the second experiment, 30% of the buffer volume contained solutions of sugars (C(3) or C(6)) or their correspondent sugar alcohol, and the final volume was completed with PIPEST-citrate buffer. Semen aliquots were extended (1:10) and dialyzed (1:50) for 2 h while cooling from 37 to 5 degrees C in semipermeable dialysis bags of 12,000 to 14,000 molecular weight cut off. The samples were frozen in pellets 1 h after dialysis was terminated. Sperm survival was significantly higher in PIPEST-citrate than in PIPEST buffer alone (P<0.05). No significant difference (P>0.05) was obtained between the use of
glucose
or lactose or between lactose and raffinose. High levels of sugar appeared to be detrimental to sperm motility of fresh and thawed semen samples. Motility of cells extended in buffers containing 30% (V/V) isosmotic solutions of
glucose
, galactose, ribose, xylose, arabinose or their correspondent sugar alcohols was significantly higher (P<0.05) than their motility in extenders without sugar.
...
PMID:Development of a buffer system for dialysis of bovine spermatozoa before freezing. II. Effect of sugars and sugar alcohols on posthaw motility. 1672 20
Three experiments were conducted to study the effect of inorganic and organic acids on survival of dialyzed bovine spermatozoa. Ejaculates were pooled, extended (1:10), dialyzed (1:50) for 2 h during cooling, and 1 h later they were frozen in pellets and stored in liquid nitrogen. The pellets were thawed in aluminum block depressions (preheated at 45 degrees C) and transferred to a test tube at room temperature as the last ice melted. Sperm motility was recorded in all samples before freezing and after thawing. The number of spermatozoa that passed through the Sephadex column was analyzed in all the postthaw samples. No statistical difference (P>0.05) was found between the use of potassium (KOH) or sodium hydroxide (NaOH) as titration bases. However, solutions containing calcium (Ca++) or magnesium (Mg++) provided significantly less (P<0.05) protection to the cells during freezing and thawing. No significant difference (P>0.05) was found in sperm survival of the postthaw samples when Ca++ or Mg++ were present. Inorganic salts of phosphates, carbonates or chloride provided significantly less protection to the cells than the control extenders with Na citrate (P<0.05). Results of the second experiment indicated that citrate, tartrate and oxalate salts provided superior (P<0.05) protection to the cells than salts of succinate, acetate or formate. It was concluded that an appropriate solution for use as a dialysate of extended bovine spermatozoa may be formulated as 30% (V/V) isosmotic Na salt of Piperazine-N-N-
BIS
(2-ethane sulfonic acid) (PIPES) plus 30% (V/V) isosmotic
glucose
plus 5% (V/V) glycerol plus 35% (V/V) of isosmotic solutions of Na or K citrate or tartrate, or a (1:1) combination of them.
...
PMID:Development of a buffer system for dialysis of bovine spermatozoa before freezing. III. Effect of different inorganic and organic salts on fresh and frozen-thawed semen. 1672 21
A field study was conducted to examine different physicochemical properties of water and various haematological and biochemical parametres of the fish Labeo rohita collected from the Ganga River (National river of India) at Varanasi district, India. The water was found to be greatly contaminated with a number of dissolved metals (Fe, Cr, Zn, Cu, Mn, Ni and Pb) whose concentrations were above the safe limits suggested by Bureau of Indian Standard (
BIS
1991) for drinking water (Fe, 1,353.33 %; Cr, 456 %; Mn, 553.33 %; Ni, 4,490 % and Pb, 1,410 %). The metal accumulation in the fish blood was very high (Fe, 2,408 %; Cr, 956.57 %; Zn, 464.90 %; Cu, 310.57 %; Mn, 1,115.48 %) in comparison to the control fish maintained under strict quality control. Lower values of the various haematological parameters (total erythrocytes count, haemoglobin, haematocrit, mean corpuscular volume and O2-carrying capacity) in the river fish in comparison to the control indicate toxic manifestation exerted by the contaminated river water on the fish. The higher level of total leucocytes count further illustrates stressed condition of the river fish. The toxic impact of the Ganga water is also expressed in the fish by the presence of higher levels of cholesterol,
glucose
, elevated activities of the enzymes aspartate amino transferase and alanine amino transferase, and lowered protein concentration.
...
PMID:Contamination of the River Ganga and its toxic implication in the blood parameters of the major carp Labeo rohita (Ham). 2345 46
Behavioral flexibility (BF) performance is influenced by both psychological and physiological factors. Recent evidence suggests that impulsivity and blood
glucose
can affect executive function, of which BF is a subdomain. Here, we hypothesized that impulsivity, fasting blood
glucose
(FBG),
glucose
changes (ie, glucoregulation) from postprandial blood
glucose
(PBG) following the intake of a 15-g
glucose
beverage could account for variability in BF performance. The Stroop Color-Word Test and the Wisconsin Card Sorting Test (WCST) were used as measures of BF, and the Barratt Impulsiveness Scale (
BIS
-11) to quantify participants' impulsivity. In Study 1, neither impulsivity nor FBG could predict performance on the Stroop or the WCST. In Study 2, we tested whether blood
glucose
levels following the intake of a sugary drink, and absolute changes in
glucose
levels following the intake of the
glucose
beverage could better predict BF. Results showed that impulsivity and the difference in blood
glucose
between time 1 (postprandial) and time 2, but not blood
glucose
levels at time 2 per se could account for variation in performance on the WCST but not on the Stroop task. More specifically, lower impulsivity scores on the
BIS
-11, and smaller differences in blood
glucose
levels from time 1 to time 2 predicted a decrease in the number of total and perseverative errors on the WCST. Our results show that measures of impulsivity and glucoregulation can be used to predict BF. Importantly our data extend the work on
glucose
and cognition to a clinically relevant domain of cognition.
...
PMID:Impulsiveness, postprandial blood glucose, and glucoregulation affect measures of behavioral flexibility. 2924 82
The Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV) took place in Madrid, Spain, on May 13-16, 2018 and was attended by 168 delegates from 28 countries. The conference provided a forum for professionals involved in basic science, clinical research, regulatory affairs, and clinical care to meet and discuss the latest advances related to discovery and development of drugs and devices aimed at improving the management of people with epilepsy. This progress report provides a summary of findings on investigational compounds for which data from preclinical or early (phase I) clinical studies were presented. The compounds reviewed include adenosine and adenosine kinase inhibitors,
BIS
-001 (huperzine A), 2-deoxy-d-
glucose
, FV-082, FV-137, JNJ-40411813, JNJ-55511118 and analogs, ketone-enhanced antiepileptic drugs, oxynytones, OV329, TAK-935 (OV935), XEN901, and XEN1101. Many innovative approaches to drug development were presented. For example, some compounds are being combined with traditional antiepileptic drugs based on evidence of synergism in seizure models, some act as inhibitors of enzymes involved in modulation of neuronal activity, and some interact in novel ways with excitatory receptors or ion channels. Some of the compounds in development target the etiology of specific epilepsy syndromes (including orphan conditions) through precision medicine, and some offer hope of producing disease-modifying effects rather than symptomatic seizure suppression. Overall, the results summarized in the report indicate that important advances are being made in the effort to develop compounds with potentially improved efficacy and safety profiles compared with existing agents.
...
PMID:Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development. 3036 92